HISUN(SH:600267) Zheng Quan Zhi Xing·2025-09-03 16:08Core Points - The Zhejiang Haizheng Pharmaceutical Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 on September 10, 2025, to discuss key proposals [1][2] - The agenda includes the revision of the remuneration management system for directors and senior management, the cancellation of the supervisory board, and amendments to the company's articles of association [3][4] Meeting Agenda - The meeting will start with the announcement of the qualification review results of attending representatives [1] - Proposals to be reviewed include the revision of the remuneration management system for directors and senior management, which has already been approved by the board [1][3] - Shareholders and their authorized representatives will have the opportunity to speak and ask questions [1] - Voting will be conducted on the proposals, followed by the counting of valid votes [1][2] - The results of the voting will be announced, and the resolutions of the shareholders' meeting will be read [1][2] Proposal Details - Proposal 1 involves the cancellation of the supervisory board and amendments to the company's articles of association, with the supervisory board's responsibilities being transferred to the audit committee of the board [3][4] - Proposal 2 focuses on the formulation, revision, and abolition of certain corporate governance systems to enhance the company's operational standards and governance structure [4]